Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
U.S. approves first drug for psychosis linked to Parkinson's
Yahoo/Reuters
Sat, 04/30/16 - 10:42 am
Parkinson's Disease Psychosis
FDA
Acadia
Nuplazid
FDA sued for hiding too much info about its expert panel members
Stat
Thu, 04/28/16 - 05:55 pm
FDA
advisory panels
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
FDA wants more from Proteus, Otsuka on ‘smart pill’
Mass Device
Wed, 04/27/16 - 10:04 pm
FDA
Proteus
Otsuka
Abilify
antidepressants
smart pills
Does FDA’s Per Se Prohibition Against Off-Label Promotion Have a Future?
FDA Law Blog
Wed, 04/27/16 - 02:10 pm
FDA
off-label
free speech
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Biotech stock crashes 50% after disclosing bad news from the FDA
Yahoo/Business Insider
Tue, 04/26/16 - 09:45 am
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy
Stat
Mon, 04/25/16 - 09:57 pm
FDA
Sarepta Therapeutics
eteplirsen
advisory panels
Duchenne Muscular Dystrophy
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAKwithout Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis
Yahoo
Mon, 04/25/16 - 06:39 pm
AbbVie
FDA
Viekira Pak
hepatitis C
Sarepta Therapeutics FDA Panel Live Blog
TheStreet.com
Mon, 04/25/16 - 08:21 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
An Investors' Guide to Sarepta's Eteplirsen FDA Advisory Panel Meeting
TheStreet.com
Mon, 04/25/16 - 07:56 am
Sarepta Therapeutics
eteplirsen
FDA
advisory panels
Duchenne Muscular Dystrophy
Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking?
Forbes
Sun, 04/24/16 - 04:32 pm
FDA
parents
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
Sarepta shares soar on FDA voting questions
CNBC
Fri, 04/22/16 - 09:38 pm
Sarepta
FDA
eteplirsen
Duchenne Muscular Dystrophy
US FDA centralizes effort to address combination product issues
Mass Device
Fri, 04/22/16 - 11:14 am
FDA
FDA Issues Draft Guidance Concerning Hospital and Health System Compounding: FDA Will Permit Compounding in Advance of a Prescription for Hospital Pharmacies
FDA Law Blog
Fri, 04/22/16 - 10:38 am
FDA
hospital compounding
compounded drugs
bluebird bio, Inc. Takes Flight Towards First Approval
Motley Fool
Thu, 04/21/16 - 10:05 am
Bluebird Bio
FDA
CCALD
Lenti-D
FDA Still Negative on Sarepta's DMD Drug, Stock Price Sinks
TheStreet.com
Thu, 04/21/16 - 08:45 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
FDA warns another Indian drug maker for serious quality control lapses
Stat
Wed, 04/20/16 - 09:43 pm
FDA
India
Sri Krishna
Roche Sees Its First Cancer Immunotherapy Winning U.S. Nod Soon
Bloomberg
Tue, 04/19/16 - 09:51 am
Roche
cancer immunotherapy
FDA
atezolizumab
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »